Advertisement Anesiva prices common stock offering - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Anesiva prices common stock offering

Anesiva has priced a common stock offering of 11.1 million shares of its common stock at $4.05 per share to raise gross proceeds of approximately $45 million, before deducting underwriting discounts and commissions or approximately $42.9 million after deducting the underwriting discounts and commissions.

The underwriters have agreed to purchase the shares from Anesiva pursuant to an underwriting agreement. Anesiva has granted the underwriters the option to purchase up to an additional 1.2 million shares of common stock to cover over-allotments, if any. The offering is expected to close on December 18, 2007, subject to customary closing conditions.

Pacific Growth Equities, Broadpoint Capital and Fortis Securities are acting as underwriters for this offering.